Manitoba HPV Disease Prevention Secretariat

The Secretariat was originally funded through the Province of Manitoba, Department of Innovation, Energy and Mines, and continues its work through project funding and contribution agreements.

Goals:

Encourage coordination and communication between different organizations and disciplines involved in the various aspects of the prevention of HPV and its consequences in Manitoba (public, private, academic sectors)
Promote Manitoba’s contribution in the Canadian effort to optimize HPV disease prevention
Increase Manitoba’s competitiveness in attracting local, national, and international HPV research to Manitoba using the linked databases and other expertise in this Province
Build Manitoba’s capacity for future HPV vaccine clinical trials by demonstrating its competitive advance
Research and pilot innovative strategies to screen for and prevent HPV-related diseases in Manitobans

Manitoba Secretariat Members and Recent Activities

Speaker Series

The Manitoba HPV Disease Prevention Secretariat of the International Centre for Infectious Diseases coordinates presentations from notable researchers, clinicians and public health specialists with a primary focus on HPV and related diseases.  A selection of presentations is listed below.

Human Papillomavirus and HPV vaccine update – considerations for Manitoba

Dr. Tim Hilderman: November 10, 2010
Tim Hilderman, MD, Medical Officer of Health, Interlake Region; Manitoba Health; Medical Director of Communicable Disease Control for Manitoba Health; Vaccine Advisor to CDC; Faculty of Medicine in the Department of Community Medicine; Community Medicine Residency Program Director; Winnipeg, Canada
Presentation synopsis
PowerPoint presentation

Current understanding of HPV vaccines - efficacy-cross protection-immunogenicity

Dr. Marina Salvadori: November 10, 2010
Marina Salvadori, MD, Infectious Diseases Consultant, Children's Hospital of Western Ontario; Associate Professor at the Schulich School of Medicine and Dentistry at the University of Western Ontario; Canadian Pediatric Society representative to the National Advisory Committee for Immunizations (NACI);  Medical Coordinator of the South Western Ontario Infection Control Network, London, Ontario, Canada
Presentation synopsis

Manitoba HPV surveillance: Burden of disease, vaccine uptake, and screening behaviours

Dr. Erich Kiewer, November 10, 2010
Erich Kliewer, PhD., Consulting Epidemiologist, CancerCare Manitoba, Winnipeg, Manitoba, Canada
Note: Presentation unavailable

Hormone therapy and breast cancer risk: Insights from observational epidemiology

Dr. Karen Canfell: June 29, 2010
Karen Canfell, D.Phil., Sydney Rotary Research Fellow, Cancer Epidemiology Research Unit, Cancer Council NSW, School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia
Presentation synopsis
PowerPoint presentation

Cervical screening in the era of HPV vaccination

Dr. Karen Canfell: June 28, 2010
Karen Canfell, D.Phil., Sydney Rotary Research Fellow, Cancer Epidemiology Research Unit, Cancer Council NSW, School of Public Health, Sydney Medical School, The University of Sydney, Sydney, Australia
Presentation synopsis
PowerPoint presentation